Guangdong Second Provincial General Hospital
Clinical trials sponsored by Guangdong Second Provincial General Hospital, explained in plain language.
-
New combo aims to keep leukemia away after remission
Disease control ENROLLING_BY_INVITATIONThis study tests whether adding venetoclax to standard chemotherapy (cytarabine) can help adults with acute myeloid leukemia (AML) stay in remission longer. About 232 participants who are already in remission will receive either the combination or chemo alone. The main goal is to…
Phase: PHASE2, PHASE3 • Sponsor: Guangdong Second Provincial General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New combo shows promise for Tough-to-Treat leukemia
Disease control ENROLLING_BY_INVITATIONThis study tests a combination of three drugs (homoharringtonine, venetoclax, and azacitidine) in 40 adults newly diagnosed with a rare and aggressive leukemia called mixed-phenotype acute leukemia (MPAL). The goal is to see if this drug combo can safely help more patients achiev…
Phase: PHASE2 • Sponsor: Guangdong Second Provincial General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC